Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Ruxolitinib in Colorectal Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ruxolitinib in Pancreatic Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE3
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)
- Status
- TERMINATED
- Phase
- PHASE3
A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)
- Status
- TERMINATED
- Phase
- PHASE2
A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.
- Status
- TERMINATED
- Phase
- PHASE2
Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.
- Status
- COMPLETED
- Phase
- PHASE3
Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 2 Study of RO7490677 In Participants With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE2